Brief report · 30 Jun 2026
Conference abstractPublished 21 Mar 2023
Hypolipidemic effect of different probiotic bacterial strains
Institute for Biological Research â??Siniša StankoviÄ?â?� - National Institute of the Republic of Serbia, University of Belgrade, Serbia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Probiotics are dietary supplements that contain various bacterial strains and have numerous benefits, including lowering lipid levels. The main question is whether all probiotic bacterial strains have this effect and, if so, to what extent. Therefore, the purpose of this review is to summarize some of the studies that address the ability of bacterial strains, used singly or in combination, to affect cholesterol and triglyceride levels in an animal model of hyperlipidemia. Methodology & Theoretical Orientation: Searches were conducted in the PubMed and Scopus databases with publication dates limited to 2012 to 2022. Findings: Probiotic mixture (Lactobacillus acidophilus and Bifidobacterium animalis) and Lactobacillus casei YBJ02 decreased cholesterol and triglycerides, as did Lactobacillus reuteri 263 but to a much greater extent triglycerides, while probiotic mixture (Lactobacillus rhamnosus Rosell-11 and Lactobacillus helveticus Rosell-52) and Lactobacillus plantarum CAI6/Lactobacillus plantarum SC4 decreased only triglycerides without effect on cholesterol in hyperlipidemic animals. Conclusion & Significance: These findings suggest that probiotic supplementation could be used as an adjunctive treatment for dyslipidemia. Since this effect is highly dependent on the probiotic bacterial strain(s), it is important to determine whether hypercholesterolemia, hypertriglyceridemia, or mixed hyperlipidemia is present before selecting and using a probiotic product.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Branka Petkovic”
